Cargando…

Efficacy and improvement of lipid profile after switching to rilpivirine in resource limited setting: real life clinical practice

BACKGROUND: Long-term success of cART is possible if the regimen is convenient and less-toxic. This study assessed the efficacy and safety of switching from a first-line NNRTI or boosted PI-based regimens to RPV-based regimens among virologically suppressed participants in resource-limited setting (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gatechompol, Sivaporn, Avihingsanon, Anchalee, Apornpong, Tanakorn, Han, Win Min, Kerr, Stephen J., Ruxrungtham, Kiat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451290/ https://www.ncbi.nlm.nih.gov/pubmed/30953533 http://dx.doi.org/10.1186/s12981-019-0222-6

Ejemplares similares

CD4/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV
por: Han, Win Min, et al.
Publicado: (2018)

Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200 cells/mm(3) in Thailand()
por: Han, Win Min, et al.
Publicado: (2020)

COVID-19 and HIV infection co-pandemics and their impact: a review of the literature
por: Gatechompol, Sivaporn, et al.
Publicado: (2021)

Association of Phenotypic Aging Marker with comorbidities, frailty and inflammatory markers in people living with HIV
por: Han, Win Min, et al.
Publicado: (2022)

Role of Rilpivirine and Etravirine in Efavirenz and Nevirapine-Based Regimens Failure in a Resource-Limited Country: A Cross- Sectional Study
por: Teeranaipong, Phairote, et al.
Publicado: (2016)

Bone mineral density among virologically suppressed Asians older than 50 years old living with and without HIV: A cross-sectional study
por: Wattanachanya, Lalita, et al.
Publicado: (2022)

Treatment outcomes and factors associated with mortality among individuals with both TB and HIV in the antiretroviral era in Thailand
por: Gatechompol, Sivaporn, et al.
Publicado: (2019)

Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: A five-year prospective study
por: Han, Win Min, et al.
Publicado: (2020)

An update on clinical utility of rilpivirine in the management of HIV infection in treatment-naïve patients
por: Putcharoen, Opass, et al.
Publicado: (2013)

Tenofovir alafenamide nephrotoxicity: a case report and literature review
por: Ueaphongsukkit, Thornthun, et al.
Publicado: (2021)

Long-term efficacy and safety of low-dose ritonavir-boosted atazanavir (ATV/r) 200/100 mg in HIV-infected Thai patients
por: Avihingsanon, A, et al.
Publicado: (2010)

Incidence and factors associated with active tuberculosis among people living with HIV after long-term antiretroviral therapy in Thailand: a competing risk model
por: Gatechompol, Sivaporn, et al.
Publicado: (2022)

Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy
por: Suwanpimolkul, Gompol, et al.
Publicado: (2022)

Prevalence of latent tuberculosis infection and feasibility of TB preventive therapy among Thai prisoners: a cross-sectional study
por: Gatechompol, Sivaporn, et al.
Publicado: (2021)

Prevalence and risk of residual viremia after ART in low- and middle-income countries: A cross-sectional study
por: Gatechompol, Sivaporn, et al.
Publicado: (2021)

Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settings
por: Ford, Nathan, et al.
Publicado: (2011)

Rationale and clinical utility of the darunavir–cobicistat combination in the treatment of HIV/AIDS
por: Putcharoen, Opass, et al.
Publicado: (2015)

Pharmaceutical Equivalence of Distributed Generic Antiretroviral (ARV) in Asian Settings: The Cross-Sectional Surveillance Study – PEDA Study
por: Sapsirisavat, Vorapot, et al.
Publicado: (2016)

Rilpivirine versus etravirine validity in NNRTI-based treatment failure in Thailand
por: Teeranaipong, Phairote, et al.
Publicado: (2014)

Bone health and HIV in resource-limited settings: a scoping review
por: Matovu, Flavia Kiweewa, et al.
Publicado: (2016)

Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings
por: Kiertiburanakul, Sasisopin, et al.
Publicado: (2017)

Challenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited Settings
por: Maek-a-Nantawat, Wirach, et al.
Publicado: (2012)

High-Sensitivity Troponins and Subclinical Coronary Atherosclerosis Evaluated by Coronary Calcium Score Among Older Asians Living With Well-Controlled Human Immunodeficiency Virus
por: Chattranukulchai, Pairoj, et al.
Publicado: (2023)

Cellular immune response of SARS-CoV-2 vaccination in kidney transplant recipients: a systematic review and meta-analysis
por: Udomkarnjananun, Suwasin, et al.
Publicado: (2023)

Adherence and Risk Behaviour in Patients with HIV Infection Receiving Antiretroviral Therapy in Bangkok
por: Clarke, Amanda, et al.
Publicado: (2012)

Low-level genital HIV shedding in Thai HIV-infected women with suppressed plasma viral load after menopause: a longitudinal study
por: Landolt, Nadia Kancheva, et al.
Publicado: (2017)

A Prediction Model of Pretreatment HIV RNA Levels in Naïve Thai HIV-infected Patients: An Application for Resource-limited Settings
por: Pongpech, Nisha, et al.
Publicado: (2017)

Soluble CD163 and monocyte populations in response to antiretroviral therapy and in relationship with neuropsychological testing among HIV-infected children
por: Ananworanich, Jintanat, et al.
Publicado: (2015)

348. Kidney Function Decline Among HIV-infected Thai Adults: Is Low Vitamin D One of the Factors?
por: Hlaing Than, Win, et al.
Publicado: (2019)

Comparable carotid intima-media thickness among long-term virologically suppressed individuals with HIV and those without HIV in Thailand
por: Putcharoen, Opass, et al.
Publicado: (2019)

Switching protease inhibitors to rilpivirine in HIV‐positive individuals with complete viral suppression and without prior HIV drug resistance in a resource‐limited setting: a randomized controlled trial
por: Palanuphap, Kulissara, et al.
Publicado: (2020)

Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: Different effects in patients with or without baseline hypercholesterolemia
por: Taramasso, Lucia, et al.
Publicado: (2019)

Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting
por: Maggi, Paolo, et al.
Publicado: (2023)

1615. Efficacy of Long-Acting Cabotegravir and Rilpivirine in a Diverse Group of Patients in a Real-World Setting
por: Yared, Nicholas F, et al.
Publicado: (2023)

The efficacy, pharmacokinetics, safety and cardiovascular risks of switching nevirapine to rilpivirine in HIV-1 patients: the RPV switch study
por: Rokx, Casper, et al.
Publicado: (2014)

Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens
por: Maggi, Paolo, et al.
Publicado: (2023)

Implementation of an online HIV prevention and treatment cascade in Thai men who have sex with men and transgender women using Adam's Love Electronic Health Record system
por: Anand, Tarandeep, et al.
Publicado: (2017)

The challenges of ending AIDS in Asia: outcomes of the Thai National AIDS Universal Coverage Programme, 2000–2014
por: Chaivooth, Suchada, et al.
Publicado: (2017)

Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand
por: Avihingsanon, Anchalee, et al.
Publicado: (2012)

Acute Hepatitis B Infection After a Switch to Long-Acting Cabotegravir and Rilpivirine
por: Pintado, Claire, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_01iei2a040uas2em8mo7vmcqu3